Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Medicinova ( (MNOV) ) just unveiled an announcement.
MediciNova, Inc. held its 2025 annual meeting of stockholders on June 17, 2025, where several key proposals were voted upon. The meeting saw the election of Carolyn Beaver as a Class III Director, the ratification of BDO USA, P.C. as the independent accounting firm, approval of executive compensation, and a decision for stockholder advisory votes on executive compensation to occur every three years.
The most recent analyst rating on (MNOV) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Medicinova stock, see the MNOV Stock Forecast page.
More about Medicinova
Average Trading Volume: 12,859
Technical Sentiment Signal: Strong Sell
Current Market Cap: $65.23M
For an in-depth examination of MNOV stock, go to TipRanks’ Overview page.